Close

Analyst Ratings for Cara Therapeutics (CARA) [Neutrals]

CARA Rating Summary

CARA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CARA
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $13.88 (+1634.4%) * Over Last 12-Mos
Rating Score: 8.3 / 10   Percentile Rank: 87%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/14/2023 Piper Sandler David Amsellem Downgrade Neutral
(Overweight)
1.00
(12.00)
1.05
(0.80)
-23.81% Details
Like CARA Ratings? Also take a look at BWXT, PLNT, BERY, OVV

CARA Ratings News